HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

On April 4, 2018, Posted by , In News, By ,, , With Comments Off on HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

Two awards at once, both carrying high monetary prizes, go to young researchers from the Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ): Simon Raffel will receive the 2018 Walter Schulz Prize for his discovery how misregulated breakdown of amino acids…

HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

On March 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of…

DKFZ- Diabetes: Are high blood glucose levels an effect rather than the cause of the disease?

On March 19, 2018, Posted by , In Research Article, By , , With Comments Off on DKFZ- Diabetes: Are high blood glucose levels an effect rather than the cause of the disease?

Insulin resistance and elevated blood glucose levels are considered to be the cause of type 2 diabetes. However, scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have now provided evidence that things might be completely different. They showed in flies that elevated levels of the metabolite…

NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

On March 13, 2018, Posted by , In Research Article, By , , With Comments Off on NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have shown in experimental studies.The combination strategy could be the key to new targeted therapies against this aggressive type of tumor. The…

NCT Heidelberg: A molecular map of childhood cancers

On March 2, 2018, Posted by , In News, By , With Comments Off on NCT Heidelberg: A molecular map of childhood cancers

Researchers led by Professor Stefan Pfister from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have been able to draw an extremely detailed molecular map of childhood cancers. In close collaboration with the German Cancer Consortium (DKTK) and the Society for Pediatric Oncology and Hematology (GPOH), they screened…